Sector: Healthcare|Industry: Drug Manufacturers - General|Market Cap: $359.99B|Employees: 131.9K
Johnson & Johnson is a healthcare company that manufactures and sells a wide range of products, including pharmaceuticals, medical devices, and consumer healthcare products. Its primary revenue streams are derived from sales to retailers, wholesalers, distributors, hospitals, and healthcare professionals. The company holds a leading market position in many of its product categories due to its strong brand recognition, extensive research and development capabilities, and global reach.
Worldwide sales reached $66.3 billion for the nine months ended September 29, 2024, a 4% increase compared to the same period in 2023. Operational growth, excluding currency fluctuations, was even stronger at 5.6%. This demonstrates robust demand for the company's products.
While revenue grew, the impact of higher input costs and supply chain disruptions is evident. Specific margin figures are needed from the 10-Q to quantify this, but the text indicates a negative impact.
The 10-Q reports a significant increase in net earnings compared to the same period in 2023. However, the exact figures are needed to assess the magnitude of the increase and its relation to the revenue growth.